These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 24529556)
1. Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth. López-Ornelas A; Vergara P; Segovia J Cytotherapy; 2014 Jul; 16(7):1011-23. PubMed ID: 24529556 [TBL] [Abstract][Full Text] [Related]
2. Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth. López-Ornelas A; Mejía-Castillo T; Vergara P; Segovia J Cancer Gene Ther; 2011 Feb; 18(2):87-99. PubMed ID: 20885451 [TBL] [Abstract][Full Text] [Related]
3. Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth. Sánchez-Hernández L; Hernández-Soto J; Vergara P; González RO; Segovia J Gene Ther; 2018 Sep; 25(6):439-449. PubMed ID: 29941984 [TBL] [Abstract][Full Text] [Related]
4. A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model. Jiménez A; López-Ornelas A; Estudillo E; González-Mariscal L; González RO; Segovia J Exp Cell Res; 2014 Oct; 327(2):307-17. PubMed ID: 24992044 [TBL] [Abstract][Full Text] [Related]
5. The systemic administration of neural stem cells expressing an inducible and soluble form of growth arrest specific 1 inhibits mammary gland tumor growth and the formation of metastases. Romero-Trejo D; Mejía-Rodríguez R; Sierra-Mondragón E; Navarrete A; Pérez-Tapia M; González RO; Segovia J Cytotherapy; 2021 Mar; 23(3):223-235. PubMed ID: 33168454 [TBL] [Abstract][Full Text] [Related]
6. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy. Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497 [TBL] [Abstract][Full Text] [Related]
7. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094 [TBL] [Abstract][Full Text] [Related]
8. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo. Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429 [TBL] [Abstract][Full Text] [Related]
9. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252 [TBL] [Abstract][Full Text] [Related]
10. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535 [TBL] [Abstract][Full Text] [Related]
11. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864 [TBL] [Abstract][Full Text] [Related]
12. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128 [TBL] [Abstract][Full Text] [Related]
13. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas. Benítez JA; Arregui L; Vergara P; Segovia J Cancer Gene Ther; 2007 Oct; 14(10):836-46. PubMed ID: 17599090 [TBL] [Abstract][Full Text] [Related]
15. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes. Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161 [TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice. Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells. Chen C; Wang Y; Goh SS; Yang J; Lam DH; Choudhury Y; Tay FC; Du S; Tan WK; Purwanti YI; Fan W; Wang S J Neurochem; 2013 Aug; 126(3):318-30. PubMed ID: 23406356 [TBL] [Abstract][Full Text] [Related]
19. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Ning S; Knox SJ Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model. Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]